These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 11205923

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
    Liao SY, Aurelio ON, Jan K, Zavada J, Stanbridge EJ.
    Cancer Res; 1997 Jul 15; 57(14):2827-31. PubMed ID: 9230182
    [Abstract] [Full Text] [Related]

  • 4. [MN/CA IX antigen as a potential target for renal cell carcinoma].
    Uemura H, Cho M, Nakagawa Y, Shimizu K, Yoshikawa M, Kim S, Hirao Y.
    Hinyokika Kiyo; 2000 Oct 15; 46(10):745-8. PubMed ID: 11215204
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The role of MN/CA IX antigen in carcinogenesis and metastasis of renal cell carcinoma].
    Nakagawa Y, Uemura H, Shimizu K, Cho M, Yoshikawa M, Hirao Y, Yoshikawa K.
    Hinyokika Kiyo; 2001 Nov 15; 47(11):809-14. PubMed ID: 11771176
    [Abstract] [Full Text] [Related]

  • 7. CA9 as a molecular marker for differential diagnosis of cystic renal tumors.
    Li G, Bilal I, Gentil-Perret A, Feng G, Zhao A, Peoc'h M, Genin C, Tostain J, Gigante M.
    Urol Oncol; 2012 Nov 15; 30(4):463-8. PubMed ID: 20822935
    [Abstract] [Full Text] [Related]

  • 8. The use of MN/CA9 gene expression in identifying malignant solid renal tumors.
    Li G, Cuilleron M, Cottier M, Gentil-Perret A, Lambert C, Genin C, Tostain J.
    Eur Urol; 2006 Feb 15; 49(2):401-5. PubMed ID: 16387417
    [Abstract] [Full Text] [Related]

  • 9. Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma.
    Brouwers AH, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC.
    Cancer Biother Radiopharm; 2003 Aug 15; 18(4):539-47. PubMed ID: 14503948
    [Abstract] [Full Text] [Related]

  • 10. Activation of the MN/CA9 gene is associated with hypomethylation in human renal cell carcinoma cell lines.
    Cho M, Grabmaier K, Kitahori Y, Hiasa Y, Nakagawa Y, Uemura H, Hirao Y, Ohnishi T, Yoshikawa K, Ooesterwijk E.
    Mol Carcinog; 2000 Mar 15; 27(3):184-9. PubMed ID: 10708480
    [Abstract] [Full Text] [Related]

  • 11. Detection of circulating MN/CA9 positive renal cell carcinoma cells during operation.
    Uemura H, Nakagawa Y, Iwai A, Okajima E, Okajima E, Yoshikawa K, Hirao Y.
    Aktuelle Urol; 2003 Jul 15; 34(4):270-2. PubMed ID: 14566683
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CA9 level in renal cyst fluid: a possible molecular diagnosis of malignant tumours.
    Li G, Feng G, Cuilleron M, Zhao A, Gentil-Perret A, Cottier M, Genin C, Tostain J.
    Histopathology; 2009 Jun 15; 54(7):880-4. PubMed ID: 19469910
    [Abstract] [Full Text] [Related]

  • 15. MN/CA9 gene expression as a potential biomarker in renal cell carcinoma.
    Murakami Y, Kanda K, Tsuji M, Kanayama H, Kagawa S.
    BJU Int; 1999 May 15; 83(7):743-7. PubMed ID: 10368188
    [Abstract] [Full Text] [Related]

  • 16. Quantification of G250 mRNA expression in renal epithelial neoplasms by real-time reverse transcription-PCR of dissected tissue from paraffin sections.
    Bismar TA, Bianco FJ, Zhang H, Li X, Sarkar FH, Sakr WA, Grignon DJ, Che M.
    Pathology; 2003 Dec 15; 35(6):513-7. PubMed ID: 14660102
    [Abstract] [Full Text] [Related]

  • 17. [Molecular detection of circulating cancer cells in patients with renal cell carcinoma].
    Uemura H.
    Hinyokika Kiyo; 1999 Aug 15; 45(8):571-5. PubMed ID: 10500965
    [Abstract] [Full Text] [Related]

  • 18. Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250.
    Grabmaier K, Vissers JL, De Weijert MC, Oosterwijk-Wakka JC, Van Bokhoven A, Brakenhoff RH, Noessner E, Mulders PA, Merkx G, Figdor CG, Adema GJ, Oosterwijk E.
    Int J Cancer; 2000 Mar 15; 85(6):865-70. PubMed ID: 10709109
    [Abstract] [Full Text] [Related]

  • 19. CA9 expression as a prognostic factor in renal clear cell carcinoma.
    Soyupak B, Erdoğan S, Ergin M, Seydaoğlu G, Kuzgunbay B, Tansuğ Z.
    Urol Int; 2005 Mar 15; 74(1):68-73. PubMed ID: 15711113
    [Abstract] [Full Text] [Related]

  • 20. Expression of carbonic anhydrase 9 at the invasion front of gastric cancers.
    Chen J, Röcken C, Hoffmann J, Krüger S, Lendeckel U, Rocco A, Pastorekova S, Malfertheiner P, Ebert MP.
    Gut; 2005 Jul 15; 54(7):920-7. PubMed ID: 15951534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.